20WAY S to Im prove P atient Care & Pharma cy cost containment Hospital Solutions by Fagron Summer 2013 I heal th system • infusi on 33 President: Gary Schneider Founded: 1980 Employees: 60+ Toll-free Phone: (800) 423-6967 Fax: (800) 339-1596 Address: 2400 Pilot Knob Road St. Paul, MN 55120 Website: fagron.us Optimization & innovation of pharmaceutical compounding with the goal of widening the therapeutic scope of the prescriber to enable tailor-made medications while supporting the unique values of the pharmacist & improving the patient’s quality of life. Company Background Since 1980, Fagron, Inc., headquartered in St. Paul, MN, is the premier provider of fine pharmaceutical ingredients, equipment, and supplies to pharmacists in the United States. Fagron has continued to grow through the years because of its innovation and ability to bring new products to the U.S. compounding market. One of Fagron’s strengths is that of offering new bases and vehicles using varying approaches to providing medication and pharmaceutical elegance to compounded preparations. We listen to our customers and work together with pharmacists, prescribers, and universities to provide the foundation for our successful optimization of pharmaceutical compounding methods. Fagron, Inc. is part of the larger Fagron Group which is headquartered in Rotterdam, the Netherlands. Fagron is focused on optimizing and innovating pharmaceutical compounding to widen prescribers’ therapeutic choices, enabling improved, focused pharmaceutical care. Fagron supports the unique position of the pharmacist in the patient’s quality of life improvement. Fagron is a total one-stop shop for compounding pharmacies. We carry innovative bases and vehicles and a wide selection of active pharmaceutical ingredients (APIs) to fit all of your needs and the equipment and supplies to compound unique dosage forms for your patients. Product Overview n SyrSpend® SF Family of Products The SyrSpend® SF family of products is an innovative line of oral compounding vehicles. This unique line of products is sugar- and alcohol-free, providing low osmolality (<50 mOsm/kg) to minimize GI upset and laxative effects. Active Suspending Technology™ holds particles in suspension longer to allow for more accurate dosing. • SyrSpend® SF is an all-in-one suspending vehicle buffered to a pH of 4.2 for maximum compatibility with active pharmaceutical ingredients (APIs). • SyrSpend® SF Alka is an easy-to-use powder for reconstitution that provides an alkaline environment for acid-labile drugs. Stability studies are being performed continuously to provide you with extended beyond-use dating. Currently available studies include: omeprazole, vancomycin, oseltamivir, propranolol, metronidazole, gabapentin, verapamil, and ursodiol in SyrSpend® SF. Visit www.syrspendsf.com for more details. n LETS KIT Convenience Pack Fagron has your solution to LETS compounding. The easy-to-use LETS kit from Fagron simplifies the compounding process by offering a convenient package containing all the pre-weighed ingredients! With the simple addition of water, each kit will make 100 milliliters of anesthetic solution. The compact packaging allows the kits to be stacked easily for quick access and inventory control. LETS – a solution of lidocaine, epinephrine, tetracaine, and sodium metabisulfite – is a proven, innovative, safe, and effective option to provide rapid topical anesthesia and is used extensively in ER settings. The Annals of Emergency Medicine published Tetracaine, Epinephrine (Adrenalin), and Cocaine (TAC) Versus Lidocaine, Epinephrine, and Tetracaine (LET) for Anesthesia of Laceration in Children (1995; 25(2): p. 203-205) which reported the duration of anesthesia experienced between TAC and LET during suturing. The study showed no statistically significant difference in efficacy and duration of anesthesia when using LET in place of TAC. By using LETS, concerns over the use of a controlled substance are eliminated and cost is dramatically reduced without compromising patient care. It has been shown to avoid the serious adverse reactions (seizures, respiratory depression, and death) that can occur when using TAC while providing the same level of anesthetic control and duration. n Drug Shortages Fagron carries a wide range of active pharmaceutical ingredients (APIs) to help get your pharmacy through drug shortages. Our high quality APIs can be used to compound capsules, oral solutions, topical preparations, and parental preparations (USP <797>). Visit our website or call us to check on the availability of various APIs before switching your patients to alternative therapies. n Increased Resources for Sterile Preparation Compounding Due to the ongoing need for sterile compounding, Fagron has expanded its resources to provide you with the equipment and supplies you need. We carry Texwipe cleaning and disinfecting products, autoclaves, sterilizers, test kits, equipment and supplies, filters, CleanStep™ Mats, and much more. Fagron also sponsors an Aseptic Technique Compounding Course through the American College of Apothecaries.
20ways Summer2013 Hospital Edition
To see the actual publication please follow the link above